A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus

Zhuo Liu, Liwei Li, Peng Hong, Guodong Zhu, Shiying Tang, Xun Zhao, Qiming Zhang, Guoliang Wang, Wei He, Hua Zhang, Heng Xue, Ligang Cui, Huiyu Ge, Jie Jiang, Shudong Zhang, Fangting Cao, Jing Yan, Fengrong Ma, Cheng Liu, Lulin Ma, Shumin Wang, Zhuo Liu, Liwei Li, Peng Hong, Guodong Zhu, Shiying Tang, Xun Zhao, Qiming Zhang, Guoliang Wang, Wei He, Hua Zhang, Heng Xue, Ligang Cui, Huiyu Ge, Jie Jiang, Shudong Zhang, Fangting Cao, Jing Yan, Fengrong Ma, Cheng Liu, Lulin Ma, Shumin Wang

Abstract

Purpose: Developed a preoperative prediction model based on multimodality imaging to evaluate the probability of inferior vena cava (IVC) vascular wall invasion due to tumor infiltration.

Materials and methods: We retrospectively analyzed the clinical data of 110 patients with renal cell carcinoma (RCC) with level I-IV tumor thrombus who underwent radical nephrectomy and IVC thrombectomy between January 2014 and April 2019. The patients were categorized into two groups: 86 patients were used to establish the imaging model, and the data validation was conducted in 24 patients. We measured the imaging parameters and used logistic regression to evaluate the uni- and multivariable associations of the clinical and radiographic features of IVC resection and established an image prediction model to assess the probability of IVC vascular wall invasion.

Results: In all of the patients, 46.5% (40/86) had IVC vascular wall invasion. The residual IVC blood flow (OR 0.170 [0.047-0.611]; P = 0.007), maximum coronal IVC diameter in mm (OR 1.203 [1.065-1.360]; P = 0.003), and presence of bland thrombus (OR 3.216 [0.870-11.887]; P = 0.080) were independent risk factors of IVC vascular wall invasion. We predicted vascular wall invasion if the probability was >42% as calculated by: {Ln [Pre/(1 - pre)] = 0.185 × maximum cornal IVC diameter + 1.168 × bland thrombus-1.770 × residual IVC blood flow-5.857}. To predict IVC vascular wall invasion, a rate of 76/86 (88.4%) was consistent with the actual treatment, and in the validation patients, 21/26 (80.8%) was consistent with the actual treatment.

Conclusions: Our model of multimodal imaging associated with IVC vascular wall invasion may be used for preoperative evaluation and prediction of the probability of partial or segmental IVC resection.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Copyright © 2020 Zhuo Liu et al.

Figures

Figure 1
Figure 1
When tumor thrombus (TT) infiltrates into the inferior vena cava (IVC) vascular wall, IVC resection is necessary. (Figure 1(a)) partial resection the IVC involved by TT is needed (Figure 1(b)), and then suture of IVC. When the inferior vena cava tumor thrombus has completely obliterated the IVC and there is a simultaneous distal long bland thrombosis in the IVC (Figure 1(d), arrow), segmental resection (Figure 1(e)) of IVC (Figure 1(f)) should be performed.
Figure 2
Figure 2
Summary of the study cohort and exclusion criteria.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curve analysis of predicted probabilities of invasion of inferior vena cava (IVC) wall invasion according to the combined with the three features: maximum coronal IVC diameter; residual IVC blood flow on ultrasound and with bland thrombus. Area under curve (AUC) of ROC is 0.899 [0.829-0.969].
Figure 4
Figure 4
Imaging and pathological findings in a 63-year-old male with clear cell renal cell carcinoma (ccRCC) in the right kidney with inferior vena cava (IVC) tumor thrombus (IVCTT, Mayo III). (a) Ultrasound images showing that the IVC is completely obstructed and has no residual blood flow. (b) Coronal gadolinium enhanced T1-weighted image showing the IVCTT and its maximum coronal diameter of 37.5 mm. The possibility of IVC invasion was 68% in this case. In consideration of tumor invasion of IVC wall, so IVC resection was performed.

References

    1. Adams L. C., Ralla B., Bender Y.-N. Y., et al. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI. Cancer Imaging. 2018;18(1):p. 17. doi: 10.1186/s40644-018-0150-z.
    1. Mastoraki A., Mastoraki S., Tsikala-Vafea M., et al. Prognostic benefit of surgical management of renal cell carcinoma invading the inferior vena cava. Indian Journal of Surgical Oncology. 2017;8(1):14–18. doi: 10.1007/s13193-016-0528-y.
    1. Shao P., Li J., Qin C., et al. Laparoscopic radical nephrectomy and inferior vena cava thrombectomy in the treatment of renal cell carcinoma. European Urology. 2015;68(1):115–122. doi: 10.1016/j.eururo.2014.12.011.
    1. Liu N. W., Wren J. D., Vertosick E., et al. The prognostic impact of a positive vascular margin on pT3 clear cell renal cell carcinoma. The Journal of Urology. 2016;195(2):264–269. doi: 10.1016/j.juro.2015.08.099.
    1. Dellaportas D., Arkadopoulos N., Tzanoglou I., et al. Technical intraoperative maneuvers for the management of inferior vena cava thrombus in renal cell carcinoma. Front Surg. 2017;4:p. 48. doi: 10.3389/fsurg.2017.00048.
    1. Gayed B. A., Youssef R., Darwish O., et al. Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 a year experience and lessons learned. BMC Urology. 2016;16:1–8.
    1. Hevia V., Ciancio G., Gómez V., Álvarez S., Díez-Nicolás V., Burgos F. J. Surgical technique for the treatment of renal cell carcinoma with inferior vena cava tumor thrombus: tips, tricks and oncological results. Springerplus. 2016;5(1):p. 132. doi: 10.1186/s40064-016-1825-1.
    1. Nini A., Capitanio U., Larcher A., et al. Perioperative and oncologic outcomes of nephrectomy and caval thrombectomy using extracorporeal circulation and deep hypothermic circulatory arrest for renal cell carcinoma invading the supradiaphragmatic inferior vena cava and/or right atrium. European Urology. 2018;73(5):793–799. doi: 10.1016/j.eururo.2017.08.019.
    1. Psutka S. P., Leibovich B. C. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Therapeutic Advances in Urology. 2015;7(4):216–229. doi: 10.1177/1756287215576443.
    1. Tilki D., Chandrasekar T., Capitanio U., et al. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC) Urologic Oncology. 2018;36(2):79.e11–79.e17. doi: 10.1016/j.urolonc.2017.10.008.
    1. O'Brien T., Fernando A., Thomas K., van Hemelrijck M., Bailey C., Austin C. Raised preoperative international normalised ratio (INR) identifies patients at high risk of perioperative death after simultaneous renal and cardiac surgery for tumours involving the peri-diaphragmatic inferior vena cava and right atrium. BJU International. 2017;119(3):424–429. doi: 10.1111/bju.13587.
    1. Xiao X., Zhang L., Chen X., et al. Surgical management of renal cell carcinoma extending into venous system: a 20-year experience. Scandinavian Journal of Surgery. 2017;107(2):158–165. doi: 10.1177/1457496917738922.
    1. Psutka S. P., Boorjian S. A., Thompson R. H., et al. Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU International. 2015;116(3):388–396. doi: 10.1111/bju.13005.
    1. Hutchinson R., Rew C., Chen G., et al. The adverse survival implications of bland thrombus in renal cell carcinoma with venous tumor thrombus. Urology. 2018;115:119–124. doi: 10.1016/j.urology.2018.02.019.
    1. Fukushima S., Uemura M., Gotoh K., et al. Xeno-pericardial patch repair of the inferior vena cava for radical resection of renal cell carcinoma with tumor thrombus. Journal of Surgical Oncology. 2017;116(6):775–782. doi: 10.1002/jso.24709.
    1. Blute M. L., Leibovich B. C., Lohse C. M., Cheville J. C., Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU International. 2004;94(1):33–41. doi: 10.1111/j.1464-410X.2004.04897.x.
    1. Quencer K. B., Friedman T., Sheth R., Oklu R. Tumor thrombus: incidence, imaging, prognosis and treatment. Cardiovascular Diagnosis and Therapy. 2017;7(S3):S165–S177. doi: 10.21037/cdt.2017.09.16.
    1. Choi D. K., Jeon H. G., Jeong C. W., et al. Surgical treatment of renal cell carcinoma: can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor? International Journal of Urology. 2017;24(2):102–109. doi: 10.1111/iju.13272.
    1. Minagawa T., Fukui D., Shingu K., Ogawa T., Okada K., Ishizuka O. Intraoperative detection of inferior vena caval tumor thrombus extending from metastatic lymph node of renal cell carcinoma using ultrasonography. Journal of Medical Ultrasonics. 2018;45:367–370. doi: 10.1007/s10396-017-0838-x.
    1. Gonzalez J. Update on surgical management of renal cell carcinoma with venous extension. Current Urology Reports. 2012;13(1):8–15. doi: 10.1007/s11934-011-0222-0.
    1. Haidar G. M., Hicks T. D., El-Sayed H. F., Davies M. G. Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2017;5(3):430–436. doi: 10.1016/j.jvsv.2016.12.011.
    1. Bansal R. K., Tu H. Y. V., Drachenberg D., et al. Laparoscopic management of advanced renal cell carcinoma with renal vein and inferior vena cava thrombus. Urology. 2014;83(4):812–817. doi: 10.1016/j.urology.2013.09.060.
    1. Hirono M., Members of the Japanese Society of Renal Cancer, Kobayashi M., et al. Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan. BMC Cancer. 2013;13(1):p. 447. doi: 10.1186/1471-2407-13-447.
    1. Overholser S., Raheem O., Zapata D., et al. Radiologic indicators prior to renal cell cancer thrombectomy: implications for vascular reconstruction and mortality. Urology Annals. 2016;8(3):312–316. doi: 10.4103/0974-7796.184888.
    1. Weiss L. Cell and tissue movements, invasion and angiogenesis. Cancer Metastasis Reviews. 2000;19(3/4):257–279. doi: 10.1023/A:1010654506661.
    1. Kaufman L. B., Yeh B. M., Breiman R. S., Joe B. N., Qayyum A., Coakley F. V. Inferior vena cava filling defects on CT and MRI. American Journal of Roentgenology. 2005;185(3):717–726. doi: 10.2214/ajr.185.3.01850717.
    1. Catalano O., Nunziata A., de Lutio di Castelguidone E., d'Errico A. G. Thrombosis and cancer: spectrum of multidetector CT findings in oncologic patients with thromboembolic disease. A pictorial review. Acta Radiologica. 2011;52(7):730–737. doi: 10.1258/ar.2011.100513.

Source: PubMed

3
Předplatit